Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
INR 34.3
(7.39%)
INR 34.3
(7.39%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.55 Million INR | -45.53% |
| 2022 | 10.19 Million INR | 179.31% |
| 2021 | 3.64 Million INR | -94.78% |
| 2020 | 69.9 Million INR | 105.86% |
| 2019 | 33.95 Million INR | 439.46% |
| 2018 | 6.29 Million INR | -49.76% |
| 2017 | 12.52 Million INR | -52.41% |
| 2016 | 26.33 Million INR | 33.36% |
| 2015 | 19.74 Million INR | -9.85% |
| 2014 | 21.9 Million INR | 60.03% |
| 2013 | 13.68 Million INR | 135.95% |
| 2012 | 5.8 Million INR | -81.87% |
| 2011 | 31.99 Million INR | -17.84% |
| 2010 | 38.94 Million INR | -32.66% |
| 2009 | 57.83 Million INR | 4.44% |
| 2008 | 55.37 Million INR | 362.3% |
| 2007 | 11.97 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 792 Thousand INR | 5.18% |
| 2023 FY | 5.55 Million INR | -45.53% |
| 2023 Q2 | 843 Thousand INR | 24.52% |
| 2023 Q4 | 753 Thousand INR | -77.04% |
| 2023 Q1 | 677 Thousand INR | -78.6% |
| 2023 Q3 | 3.27 Million INR | 288.97% |
| 2022 Q4 | 3.16 Million INR | -25.95% |
| 2022 Q2 | 676 Thousand INR | -67.47% |
| 2022 Q1 | 2.07 Million INR | 41.9% |
| 2022 FY | 10.19 Million INR | 179.31% |
| 2022 Q3 | 4.27 Million INR | 532.1% |
| 2021 Q4 | 1.46 Million INR | -8.18% |
| 2021 Q3 | 1.59 Million INR | 345.53% |
| 2021 Q2 | 358 Thousand INR | 54.31% |
| 2021 Q1 | 232 Thousand INR | -99.49% |
| 2021 FY | 3.64 Million INR | -94.78% |
| 2020 Q4 | 45.2 Million INR | 308.38% |
| 2020 Q3 | 11.07 Million INR | 3.37% |
| 2020 Q2 | 10.7 Million INR | 266.62% |
| 2020 Q1 | 2.92 Million INR | -66.05% |
| 2020 FY | 69.9 Million INR | 105.86% |
| 2019 Q4 | 8.6 Million INR | 45.15% |
| 2019 Q1 | 18.85 Million INR | 1134.8% |
| 2019 Q3 | 5.92 Million INR | 938.18% |
| 2019 FY | 33.95 Million INR | 439.46% |
| 2019 Q2 | 571 Thousand INR | -96.97% |
| 2018 Q1 | 1.38 Million INR | 264.47% |
| 2018 Q3 | 2.83 Million INR | 421.69% |
| 2018 Q4 | 1.52 Million INR | -46.19% |
| 2018 FY | 6.29 Million INR | -49.76% |
| 2018 Q2 | 544 Thousand INR | -60.72% |
| 2017 Q4 | 380 Thousand INR | -70.22% |
| 2017 Q2 | 5.35 Million INR | -2.9% |
| 2017 FY | 12.52 Million INR | -52.41% |
| 2017 Q1 | 5.51 Million INR | -23.88% |
| 2017 Q3 | 1.27 Million INR | -76.19% |
| 2016 Q4 | 7.24 Million INR | -8.48% |
| 2016 FY | 26.33 Million INR | 33.36% |
| 2016 Q3 | 7.92 Million INR | 1129.97% |
| 2016 Q2 | 644 Thousand INR | -93.88% |
| 2016 Q1 | 10.51 Million INR | 105.23% |
| 2015 FY | 19.74 Million INR | -9.85% |
| 2015 Q3 | 1.58 Million INR | -26.7% |
| 2015 Q4 | 5.12 Million INR | 224.1% |
| 2015 Q1 | 10.88 Million INR | 1341.94% |
| 2015 Q2 | 2.15 Million INR | -80.18% |
| 2014 Q3 | 14.74 Million INR | 282.91% |
| 2014 Q1 | 2.55 Million INR | -48.6% |
| 2014 FY | 21.9 Million INR | 60.03% |
| 2014 Q2 | 3.85 Million INR | 50.9% |
| 2014 Q4 | 754.6 Thousand INR | -94.88% |
| 2013 Q3 | 1.85 Million INR | 221.18% |
| 2013 Q4 | 4.96 Million INR | 168.39% |
| 2013 FY | 13.68 Million INR | 135.95% |
| 2013 Q1 | 6.29 Million INR | 773.53% |
| 2013 Q2 | 576 Thousand INR | -90.85% |
| 2012 Q4 | 720.52 Thousand INR | -64.45% |
| 2012 Q1 | 1.78 Million INR | -53.01% |
| 2012 FY | 5.8 Million INR | -81.87% |
| 2012 Q3 | 2.02 Million INR | 59.48% |
| 2012 Q2 | 1.27 Million INR | -28.68% |
| 2011 Q4 | 3.79 Million INR | 168.19% |
| 2011 Q3 | 1.41 Million INR | 0.0% |
| 2011 FY | 31.99 Million INR | -17.84% |
| 2010 FY | 38.94 Million INR | -32.66% |
| 2009 FY | 57.83 Million INR | 4.44% |
| 2008 Q4 | 1.11 Million INR | 0.0% |
| 2008 FY | 55.37 Million INR | 362.3% |
| 2007 FY | 11.97 Million INR | 0.0% |
| 2007 Q4 | 9.35 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 362.75 Million INR | 98.469% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 99.673% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | 96.344% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.99% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 99.62% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 99.725% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | 99.353% |
| Beryl Drugs Limited | 271.24 Million INR | 97.953% |
| Cian Healthcare Limited | 616.95 Million INR | 99.1% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | 69.797% |
| Concord Drugs Limited | 449.24 Million INR | 98.764% |
| Deccan Health Care Limited | 597.28 Million INR | 99.07% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 98.843% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | 47.071% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 99.609% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 99.471% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 99.819% |
| Makers Laboratories Limited | 1.03 Billion INR | 99.465% |
| Medi-Caps Limited | 265.63 Million INR | 97.91% |
| Panchsheel Organics Limited | 1.05 Billion INR | 99.472% |
| Parmax Pharma Limited | 154.24 Million INR | 96.4% |
| Parnax Lab Limited | 1.88 Billion INR | 99.706% |
| Patidar Buildcon Limited | 2.3 Million INR | -140.555% |
| Phaarmasia Limited | 305.93 Million INR | 98.185% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 99.557% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 98.966% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -396.601% |
| Smruthi Organics Limited | 1.27 Billion INR | 99.565% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 97.966% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 99.88% |
| Trident Lifeline Limited | 446.28 Million INR | 98.756% |
| Transchem Limited | 4.09 Million INR | -35.415% |
| Trinity League India Limited | 2.95 Million INR | -88.203% |
| Tyche Industries Limited | 696.83 Million INR | 99.203% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | 94.603% |
| Vivanza Biosciences Limited | 278.89 Million INR | 98.009% |
| PRAVEG LIMITED | 915.96 Million INR | 99.394% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 99.959% |
| Sunil Healthcare Limited | 901.91 Million INR | 99.384% |
| Syschem (India) Limited | 2.33 Billion INR | 99.762% |
| Zenith Healthcare Limited | 144.71 Million INR | 96.164% |
| Zenlabs Ethica Limited | 585.63 Million INR | 99.052% |
| Mercury Laboratories Limited | 755.59 Million INR | 99.265% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 98.613% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 98.5% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 98.755% |
| Roopa Industries Limited | 715.53 Million INR | 99.224% |
| PANJON LTD. | 125.52 Million INR | 95.577% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | 96.326% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 99.914% |
| Crestchem Limited | 212.56 Million INR | 97.388% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 99.175% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 99.841% |
| Trimurthi Limited | 42.23 Million INR | 86.855% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 99.255% |
| Norris Medicines Limited | 56.35 Million INR | 90.148% |
| Veerhealth Care Limited | 142.13 Million INR | 96.094% |
| Lactose (India) Limited | 1.13 Billion INR | 99.513% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 98.599% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 99.682% |
| Gennex Laboratories Limited | 867.14 Million INR | 99.36% |
| Denis Chem Lab Limited | 1.67 Billion INR | 99.669% |
| Colinz Laboratories Limited | 70.29 Million INR | 92.102% |
| Godavari Drugs Limited | 1.56 Billion INR | 99.646% |
| Zenotech Laboratories Limited | 368.08 Million INR | 98.492% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 99.559% |
| Bharat Parenterals Limited | 2.59 Billion INR | 99.786% |
| Coral Laboratories Limited | 836.6 Million INR | 99.336% |
| Evoq Remedies Limited | 63.09 Million INR | 91.2% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 99.457% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 99.643% |
| Auro Laboratories Limited | 526.99 Million INR | 98.946% |